Sample_geo_ID	title	geo_accession	status	submission_date	last_update_date	type	channel_count	source_name_ch1	organism_ch1	characteristics_ch1	characteristics_ch1.1	characteristics_ch1.2	characteristics_ch1.3	treatment_protocol_ch1	molecule_ch1	extract_protocol_ch1	label_ch1	label_protocol_ch1	taxid_ch1	hyb_protocol	scan_protocol	description	data_processing	platform_id	contact_name	contact_email	contact_phone	contact_laboratory	contact_department	contact_institute	contact_address	contact_city	contact_state	contact_zip/postal_code	contact_country	supplementary_file	data_row_count	status:ch1	surgery outcome:ch1	survival years:ch1	tissue:ch1
GSM657519	Normal HOSE2237	GSM657519	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian surface epithelial cells	Homo sapiens	tissue: Normal ovarian surface epithelium				Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from ovarian surface epithelial cells	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657519/suppl/GSM657519_HOSE2237.CEL.gz	22283	NA	NA	NA	Normal ovarian surface epithelium
GSM657520	Normal HOSE2008	GSM657520	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian surface epithelial cells	Homo sapiens	tissue: Normal ovarian surface epithelium				Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from ovarian surface epithelial cells	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657520/suppl/GSM657520_HOSE2008.CEL.gz	22283	NA	NA	NA	Normal ovarian surface epithelium
GSM657521	Normal HOSE2061	GSM657521	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian surface epithelial cells	Homo sapiens	tissue: Normal ovarian surface epithelium				Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from ovarian surface epithelial cells	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657521/suppl/GSM657521_HOSE2061.CEL.gz	22283	NA	NA	NA	Normal ovarian surface epithelium
GSM657522	Normal HOSE2064	GSM657522	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian surface epithelial cells	Homo sapiens	tissue: Normal ovarian surface epithelium				Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from ovarian surface epithelial cells	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657522/suppl/GSM657522_HOSE2064.CEL.gz	22283	NA	NA	NA	Normal ovarian surface epithelium
GSM657523	Normal HOSE2085	GSM657523	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian surface epithelial cells	Homo sapiens	tissue: Normal ovarian surface epithelium				Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from ovarian surface epithelial cells	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657523/suppl/GSM657523_HOSE2085.CEL.gz	22283	NA	NA	NA	Normal ovarian surface epithelium
GSM657524	Normal HOSE2225	GSM657524	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian surface epithelial cells	Homo sapiens	tissue: Normal ovarian surface epithelium				Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from ovarian surface epithelial cells	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657524/suppl/GSM657524_HOSE2225.CEL.gz	22283	NA	NA	NA	Normal ovarian surface epithelium
GSM657525	Normal HOSE2226	GSM657525	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian surface epithelial cells	Homo sapiens	tissue: Normal ovarian surface epithelium				Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from ovarian surface epithelial cells	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657525/suppl/GSM657525_HOSE2226.CEL.gz	22283	NA	NA	NA	Normal ovarian surface epithelium
GSM657526	Normal HOSE2228	GSM657526	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian surface epithelial cells	Homo sapiens	tissue: Normal ovarian surface epithelium				Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from ovarian surface epithelial cells	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657526/suppl/GSM657526_HOSE2228.CEL.gz	22283	NA	NA	NA	Normal ovarian surface epithelium
GSM657527	Normal HOSE2230	GSM657527	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian surface epithelial cells	Homo sapiens	tissue: Normal ovarian surface epithelium				Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from ovarian surface epithelial cells	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657527/suppl/GSM657527_HOSE2230.CEL.gz	22283	NA	NA	NA	Normal ovarian surface epithelium
GSM657528	Normal HOSE2234	GSM657528	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian surface epithelial cells	Homo sapiens	tissue: Normal ovarian surface epithelium				Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from ovarian surface epithelial cells	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657528/suppl/GSM657528_HOSE2234.CEL.gz	22283	NA	NA	NA	Normal ovarian surface epithelium
GSM657529	Ovarian Cancer SO10	GSM657529	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 7.48	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657529/suppl/GSM657529_SO10.CEL.gz	22283	AWD (alive with disease)	Optimal	7.48	Late-stage high-grade ovarian cancer
GSM657530	Ovarian Cancer SO100	GSM657530	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 4.51	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657530/suppl/GSM657530_SO100.CEL.gz	22283	NED (no evidence of disease)	Optimal	4.51	Late-stage high-grade ovarian cancer
GSM657531	Ovarian Cancer SO103	GSM657531	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 4.38	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657531/suppl/GSM657531_SO103.CEL.gz	22283	NED (no evidence of disease)	Optimal	4.38	Late-stage high-grade ovarian cancer
GSM657532	Ovarian Cancer SO106	GSM657532	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 1.72	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657532/suppl/GSM657532_SO106.CEL.gz	22283	DOD (dead of disease)	Optimal	1.72	Late-stage high-grade ovarian cancer
GSM657533	Ovarian Cancer SO108	GSM657533	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 3.99	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657533/suppl/GSM657533_SO108.CEL.gz	22283	AWD (alive with disease)	Optimal	3.99	Late-stage high-grade ovarian cancer
GSM657534	Ovarian Cancer SO11	GSM657534	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 2.51	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657534/suppl/GSM657534_SO11.CEL.gz	22283	DOD (dead of disease)	Optimal	2.51	Late-stage high-grade ovarian cancer
GSM657535	Ovarian Cancer SO113	GSM657535	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 3.77	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657535/suppl/GSM657535_SO113.CEL.gz	22283	NED (no evidence of disease)	Optimal	3.77	Late-stage high-grade ovarian cancer
GSM657536	Ovarian Cancer SO115	GSM657536	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 2.45	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657536/suppl/GSM657536_SO115.CEL.gz	22283	DOD (dead of disease)	Optimal	2.45	Late-stage high-grade ovarian cancer
GSM657537	Ovarian Cancer SO116	GSM657537	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 3.58	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657537/suppl/GSM657537_SO116.CEL.gz	22283	AWD (alive with disease)	Optimal	3.58	Late-stage high-grade ovarian cancer
GSM657538	Ovarian Cancer SO117	GSM657538	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 3.53	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657538/suppl/GSM657538_SO117.CEL.gz	22283	AWD (alive with disease)	Optimal	3.53	Late-stage high-grade ovarian cancer
GSM657539	Ovarian Cancer SO118	GSM657539	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: AWD (alive with disease)	survival years: 3.49	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657539/suppl/GSM657539_SO118.CEL.gz	22283	AWD (alive with disease)	Suboptimal	3.49	Late-stage high-grade ovarian cancer
GSM657540	Ovarian Cancer SO12	GSM657540	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 0.71	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657540/suppl/GSM657540_SO12.CEL.gz	22283	DOD (dead of disease)	Optimal	0.71	Late-stage high-grade ovarian cancer
GSM657541	Ovarian Cancer SO121	GSM657541	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 3.3	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657541/suppl/GSM657541_SO121.CEL.gz	22283	NED (no evidence of disease)	Optimal	3.3	Late-stage high-grade ovarian cancer
GSM657542	Ovarian Cancer SO122	GSM657542	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 2.3	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657542/suppl/GSM657542_SO122.CEL.gz	22283	DOD (dead of disease)	Optimal	2.3	Late-stage high-grade ovarian cancer
GSM657543	Ovarian Cancer SO124	GSM657543	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 3.26	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657543/suppl/GSM657543_SO124.CEL.gz	22283	NED (no evidence of disease)	Optimal	3.26	Late-stage high-grade ovarian cancer
GSM657544	Ovarian Cancer SO129	GSM657544	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 2.82	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657544/suppl/GSM657544_SO129.CEL.gz	22283	NED (no evidence of disease)	Optimal	2.82	Late-stage high-grade ovarian cancer
GSM657545	Ovarian Cancer SO13	GSM657545	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: NED (no evidence of disease)	survival years: 7.33	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657545/suppl/GSM657545_SO13.CEL.gz	22283	NED (no evidence of disease)	Suboptimal	7.33	Late-stage high-grade ovarian cancer
GSM657546	Ovarian Cancer SO131	GSM657546	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 2.94	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657546/suppl/GSM657546_SO131.CEL.gz	22283	NED (no evidence of disease)	Optimal	2.94	Late-stage high-grade ovarian cancer
GSM657547	Ovarian Cancer SO134	GSM657547	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 1.03	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657547/suppl/GSM657547_SO134.CEL.gz	22283	DOD (dead of disease)	Optimal	1.03	Late-stage high-grade ovarian cancer
GSM657548	Ovarian Cancer SO135	GSM657548	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 3.55	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657548/suppl/GSM657548_SO135.CEL.gz	22283	DOD (dead of disease)	Optimal	3.55	Late-stage high-grade ovarian cancer
GSM657549	Ovarian Cancer SO137	GSM657549	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.17	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657549/suppl/GSM657549_SO137.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.17	Late-stage high-grade ovarian cancer
GSM657550	Ovarian Cancer SO141	GSM657550	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.47	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657550/suppl/GSM657550_SO141.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.47	Late-stage high-grade ovarian cancer
GSM657551	Ovarian Cancer SO143	GSM657551	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 6.86	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657551/suppl/GSM657551_SO143.CEL.gz	22283	AWD (alive with disease)	Optimal	6.86	Late-stage high-grade ovarian cancer
GSM657552	Ovarian Cancer SO148	GSM657552	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 2.37	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657552/suppl/GSM657552_SO148.CEL.gz	22283	DOD (dead of disease)	Suboptimal	2.37	Late-stage high-grade ovarian cancer
GSM657553	Ovarian Cancer SO154	GSM657553	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: AWD (alive with disease)	survival years: 3.7	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657553/suppl/GSM657553_SO154.CEL.gz	22283	AWD (alive with disease)	Suboptimal	3.7	Late-stage high-grade ovarian cancer
GSM657554	Ovarian Cancer SO16	GSM657554	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 6.29	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657554/suppl/GSM657554_SO16.CEL.gz	22283	DOD (dead of disease)	Suboptimal	6.29	Late-stage high-grade ovarian cancer
GSM657555	Ovarian Cancer SO166	GSM657555	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 2.93	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657555/suppl/GSM657555_SO166.CEL.gz	22283	NED (no evidence of disease)	Optimal	2.93	Late-stage high-grade ovarian cancer
GSM657556	Ovarian Cancer SO17	GSM657556	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 3.83	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657556/suppl/GSM657556_SO17.CEL.gz	22283	DOD (dead of disease)	Suboptimal	3.83	Late-stage high-grade ovarian cancer
GSM657557	Ovarian Cancer SO173	GSM657557	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 2.71	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657557/suppl/GSM657557_SO173.CEL.gz	22283	AWD (alive with disease)	Optimal	2.71	Late-stage high-grade ovarian cancer
GSM657558	Ovarian Cancer SO174	GSM657558	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 2.84	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657558/suppl/GSM657558_SO174.CEL.gz	22283	DOD (dead of disease)	Suboptimal	2.84	Late-stage high-grade ovarian cancer
GSM657559	Ovarian Cancer SO18	GSM657559	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 6.3	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657559/suppl/GSM657559_SO18.CEL.gz	22283	DOD (dead of disease)	Optimal	6.3	Late-stage high-grade ovarian cancer
GSM657560	Ovarian Cancer SO181	GSM657560	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 2.1	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657560/suppl/GSM657560_SO181.CEL.gz	22283	NED (no evidence of disease)	Optimal	2.1	Late-stage high-grade ovarian cancer
GSM657561	Ovarian Cancer SO184	GSM657561	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 2.43	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657561/suppl/GSM657561_SO184.CEL.gz	22283	NED (no evidence of disease)	Optimal	2.43	Late-stage high-grade ovarian cancer
GSM657562	Ovarian Cancer SO185	GSM657562	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 2.37	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657562/suppl/GSM657562_SO185.CEL.gz	22283	NED (no evidence of disease)	Optimal	2.37	Late-stage high-grade ovarian cancer
GSM657563	Ovarian Cancer SO187	GSM657563	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 2.48	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657563/suppl/GSM657563_SO187.CEL.gz	22283	AWD (alive with disease)	Optimal	2.48	Late-stage high-grade ovarian cancer
GSM657564	Ovarian Cancer SO189	GSM657564	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 2.3	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657564/suppl/GSM657564_SO189.CEL.gz	22283	NED (no evidence of disease)	Optimal	2.3	Late-stage high-grade ovarian cancer
GSM657565	Ovarian Cancer SO190	GSM657565	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 2.16	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657565/suppl/GSM657565_SO190.CEL.gz	22283	DOD (dead of disease)	Optimal	2.16	Late-stage high-grade ovarian cancer
GSM657566	Ovarian Cancer SO193	GSM657566	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 2.27	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657566/suppl/GSM657566_SO193.CEL.gz	22283	AWD (alive with disease)	Optimal	2.27	Late-stage high-grade ovarian cancer
GSM657567	Ovarian Cancer SO194	GSM657567	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 2.23	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657567/suppl/GSM657567_SO194.CEL.gz	22283	AWD (alive with disease)	Optimal	2.23	Late-stage high-grade ovarian cancer
GSM657568	Ovarian Cancer SO196	GSM657568	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 1.28	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657568/suppl/GSM657568_SO196.CEL.gz	22283	DOD (dead of disease)	Optimal	1.28	Late-stage high-grade ovarian cancer
GSM657569	Ovarian Cancer SO197	GSM657569	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 2.16	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657569/suppl/GSM657569_SO197.CEL.gz	22283	AWD (alive with disease)	Optimal	2.16	Late-stage high-grade ovarian cancer
GSM657570	Ovarian Cancer SO2	GSM657570	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 2.83	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657570/suppl/GSM657570_SO2.CEL.gz	22283	DOD (dead of disease)	Suboptimal	2.83	Late-stage high-grade ovarian cancer
GSM657571	Ovarian Cancer SO200	GSM657571	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 2.15	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657571/suppl/GSM657571_SO200.CEL.gz	22283	AWD (alive with disease)	Optimal	2.15	Late-stage high-grade ovarian cancer
GSM657572	Ovarian Cancer SO201	GSM657572	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 2.06	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657572/suppl/GSM657572_SO201.CEL.gz	22283	AWD (alive with disease)	Optimal	2.06	Late-stage high-grade ovarian cancer
GSM657573	Ovarian Cancer SO203	GSM657573	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 1.59	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657573/suppl/GSM657573_SO203.CEL.gz	22283	DOD (dead of disease)	Optimal	1.59	Late-stage high-grade ovarian cancer
GSM657574	Ovarian Cancer SO205	GSM657574	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 1.89	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657574/suppl/GSM657574_SO205.CEL.gz	22283	NED (no evidence of disease)	Optimal	1.89	Late-stage high-grade ovarian cancer
GSM657575	Ovarian Cancer SO21	GSM657575	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 0.56	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657575/suppl/GSM657575_SO21.CEL.gz	22283	DOD (dead of disease)	Optimal	0.56	Late-stage high-grade ovarian cancer
GSM657576	Ovarian Cancer SO211	GSM657576	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 4.94	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657576/suppl/GSM657576_SO211.CEL.gz	22283	DOD (dead of disease)	Suboptimal	4.94	Late-stage high-grade ovarian cancer
GSM657577	Ovarian Cancer SO214	GSM657577	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 2.96	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657577/suppl/GSM657577_SO214.CEL.gz	22283	DOD (dead of disease)	Suboptimal	2.96	Late-stage high-grade ovarian cancer
GSM657578	Ovarian Cancer SO216	GSM657578	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.75	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657578/suppl/GSM657578_SO216.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.75	Late-stage high-grade ovarian cancer
GSM657579	Ovarian Cancer SO217	GSM657579	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.91	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657579/suppl/GSM657579_SO217.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.91	Late-stage high-grade ovarian cancer
GSM657580	Ovarian Cancer SO218	GSM657580	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 4.6	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657580/suppl/GSM657580_SO218.CEL.gz	22283	DOD (dead of disease)	Optimal	4.6	Late-stage high-grade ovarian cancer
GSM657581	Ovarian Cancer SO224	GSM657581	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 3.18	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657581/suppl/GSM657581_SO224.CEL.gz	22283	DOD (dead of disease)	Suboptimal	3.18	Late-stage high-grade ovarian cancer
GSM657582	Ovarian Cancer SO225	GSM657582	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 8.8	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657582/suppl/GSM657582_SO225.CEL.gz	22283	DOD (dead of disease)	Optimal	8.8	Late-stage high-grade ovarian cancer
GSM657583	Ovarian Cancer SO227	GSM657583	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 5.68	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657583/suppl/GSM657583_SO227.CEL.gz	22283	DOD (dead of disease)	Suboptimal	5.68	Late-stage high-grade ovarian cancer
GSM657584	Ovarian Cancer SO228	GSM657584	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 6.75	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657584/suppl/GSM657584_SO228.CEL.gz	22283	DOD (dead of disease)	Optimal	6.75	Late-stage high-grade ovarian cancer
GSM657585	Ovarian Cancer SO229	GSM657585	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.86	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657585/suppl/GSM657585_SO229.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.86	Late-stage high-grade ovarian cancer
GSM657586	Ovarian Cancer SO23	GSM657586	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 6.91	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657586/suppl/GSM657586_SO23.CEL.gz	22283	NED (no evidence of disease)	Optimal	6.91	Late-stage high-grade ovarian cancer
GSM657587	Ovarian Cancer SO230	GSM657587	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 3.64	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657587/suppl/GSM657587_SO230.CEL.gz	22283	DOD (dead of disease)	Optimal	3.64	Late-stage high-grade ovarian cancer
GSM657588	Ovarian Cancer SO231	GSM657588	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 5.15	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657588/suppl/GSM657588_SO231.CEL.gz	22283	DOD (dead of disease)	Optimal	5.15	Late-stage high-grade ovarian cancer
GSM657589	Ovarian Cancer SO235	GSM657589	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.62	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657589/suppl/GSM657589_SO235.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.62	Late-stage high-grade ovarian cancer
GSM657590	Ovarian Cancer SO236	GSM657590	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 13.5	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657590/suppl/GSM657590_SO236.CEL.gz	22283	NED (no evidence of disease)	Optimal	13.5	Late-stage high-grade ovarian cancer
GSM657591	Ovarian Cancer SO237	GSM657591	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.59	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657591/suppl/GSM657591_SO237.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.59	Late-stage high-grade ovarian cancer
GSM657592	Ovarian Cancer SO241	GSM657592	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 3.12	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657592/suppl/GSM657592_SO241.CEL.gz	22283	DOD (dead of disease)	Suboptimal	3.12	Late-stage high-grade ovarian cancer
GSM657593	Ovarian Cancer SO242	GSM657593	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.21	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657593/suppl/GSM657593_SO242.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.21	Late-stage high-grade ovarian cancer
GSM657594	Ovarian Cancer SO243	GSM657594	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 13.1	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657594/suppl/GSM657594_SO243.CEL.gz	22283	NED (no evidence of disease)	Optimal	13.1	Late-stage high-grade ovarian cancer
GSM657595	Ovarian Cancer SO244	GSM657595	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.99	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657595/suppl/GSM657595_SO244.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.99	Late-stage high-grade ovarian cancer
GSM657596	Ovarian Cancer SO246	GSM657596	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 3.95	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657596/suppl/GSM657596_SO246.CEL.gz	22283	DOD (dead of disease)	Optimal	3.95	Late-stage high-grade ovarian cancer
GSM657597	Ovarian Cancer SO247	GSM657597	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 5.34	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657597/suppl/GSM657597_SO247.CEL.gz	22283	DOD (dead of disease)	Suboptimal	5.34	Late-stage high-grade ovarian cancer
GSM657598	Ovarian Cancer SO249	GSM657598	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 6.83	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657598/suppl/GSM657598_SO249.CEL.gz	22283	DOD (dead of disease)	Suboptimal	6.83	Late-stage high-grade ovarian cancer
GSM657599	Ovarian Cancer SO25	GSM657599	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 3.5	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657599/suppl/GSM657599_SO25.CEL.gz	22283	DOD (dead of disease)	Optimal	3.5	Late-stage high-grade ovarian cancer
GSM657600	Ovarian Cancer SO250	GSM657600	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 8.64	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657600/suppl/GSM657600_SO250.CEL.gz	22283	DOD (dead of disease)	Suboptimal	8.64	Late-stage high-grade ovarian cancer
GSM657601	Ovarian Cancer SO256	GSM657601	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.94	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657601/suppl/GSM657601_SO256.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.94	Late-stage high-grade ovarian cancer
GSM657602	Ovarian Cancer SO257	GSM657602	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 2.2	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657602/suppl/GSM657602_SO257.CEL.gz	22283	DOD (dead of disease)	Suboptimal	2.2	Late-stage high-grade ovarian cancer
GSM657603	Ovarian Cancer SO258	GSM657603	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.72	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657603/suppl/GSM657603_SO258.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.72	Late-stage high-grade ovarian cancer
GSM657604	Ovarian Cancer SO261	GSM657604	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.98	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657604/suppl/GSM657604_SO261.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.98	Late-stage high-grade ovarian cancer
GSM657605	Ovarian Cancer SO262	GSM657605	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 7.88	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657605/suppl/GSM657605_SO262.CEL.gz	22283	DOD (dead of disease)	Suboptimal	7.88	Late-stage high-grade ovarian cancer
GSM657606	Ovarian Cancer SO263	GSM657606	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 3.93	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657606/suppl/GSM657606_SO263.CEL.gz	22283	DOD (dead of disease)	Suboptimal	3.93	Late-stage high-grade ovarian cancer
GSM657607	Ovarian Cancer SO265	GSM657607	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.33	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657607/suppl/GSM657607_SO265.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.33	Late-stage high-grade ovarian cancer
GSM657608	Ovarian Cancer SO267	GSM657608	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.3	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657608/suppl/GSM657608_SO267.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.3	Late-stage high-grade ovarian cancer
GSM657609	Ovarian Cancer SO268	GSM657609	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 9.22	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657609/suppl/GSM657609_SO268.CEL.gz	22283	DOD (dead of disease)	Optimal	9.22	Late-stage high-grade ovarian cancer
GSM657610	Ovarian Cancer SO272	GSM657610	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 3.75	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657610/suppl/GSM657610_SO272.CEL.gz	22283	DOD (dead of disease)	Suboptimal	3.75	Late-stage high-grade ovarian cancer
GSM657611	Ovarian Cancer SO273	GSM657611	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 2.52	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657611/suppl/GSM657611_SO273.CEL.gz	22283	DOD (dead of disease)	Optimal	2.52	Late-stage high-grade ovarian cancer
GSM657612	Ovarian Cancer SO278	GSM657612	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 4.53	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657612/suppl/GSM657612_SO278.CEL.gz	22283	DOD (dead of disease)	Optimal	4.53	Late-stage high-grade ovarian cancer
GSM657613	Ovarian Cancer SO279	GSM657613	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.92	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657613/suppl/GSM657613_SO279.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.92	Late-stage high-grade ovarian cancer
GSM657614	Ovarian Cancer SO282	GSM657614	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 2.4	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657614/suppl/GSM657614_SO282.CEL.gz	22283	DOD (dead of disease)	Suboptimal	2.4	Late-stage high-grade ovarian cancer
GSM657615	Ovarian Cancer SO283	GSM657615	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.66	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657615/suppl/GSM657615_SO283.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.66	Late-stage high-grade ovarian cancer
GSM657616	Ovarian Cancer SO285	GSM657616	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 2.32	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657616/suppl/GSM657616_SO285.CEL.gz	22283	DOD (dead of disease)	Suboptimal	2.32	Late-stage high-grade ovarian cancer
GSM657617	Ovarian Cancer SO290	GSM657617	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 3.5	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657617/suppl/GSM657617_SO290.CEL.gz	22283	DOD (dead of disease)	Optimal	3.5	Late-stage high-grade ovarian cancer
GSM657618	Ovarian Cancer SO295	GSM657618	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 3.24	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657618/suppl/GSM657618_SO295.CEL.gz	22283	DOD (dead of disease)	Suboptimal	3.24	Late-stage high-grade ovarian cancer
GSM657619	Ovarian Cancer SO299	GSM657619	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.06	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657619/suppl/GSM657619_SO299.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.06	Late-stage high-grade ovarian cancer
GSM657620	Ovarian Cancer SO300	GSM657620	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 0.36	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657620/suppl/GSM657620_SO300.CEL.gz	22283	NED (no evidence of disease)	Optimal	0.36	Late-stage high-grade ovarian cancer
GSM657621	Ovarian Cancer SO301	GSM657621	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 2.99	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657621/suppl/GSM657621_SO301.CEL.gz	22283	DOD (dead of disease)	Suboptimal	2.99	Late-stage high-grade ovarian cancer
GSM657622	Ovarian Cancer SO303	GSM657622	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 1.55	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657622/suppl/GSM657622_SO303.CEL.gz	22283	DOD (dead of disease)	Optimal	1.55	Late-stage high-grade ovarian cancer
GSM657623	Ovarian Cancer SO308	GSM657623	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 4.83	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657623/suppl/GSM657623_SO308.CEL.gz	22283	DOD (dead of disease)	Optimal	4.83	Late-stage high-grade ovarian cancer
GSM657624	Ovarian Cancer SO31	GSM657624	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 4.12	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657624/suppl/GSM657624_SO31.CEL.gz	22283	DOD (dead of disease)	Suboptimal	4.12	Late-stage high-grade ovarian cancer
GSM657625	Ovarian Cancer SO312	GSM657625	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.56	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657625/suppl/GSM657625_SO312.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.56	Late-stage high-grade ovarian cancer
GSM657626	Ovarian Cancer SO322	GSM657626	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 3.99	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657626/suppl/GSM657626_SO322.CEL.gz	22283	DOD (dead of disease)	Optimal	3.99	Late-stage high-grade ovarian cancer
GSM657627	Ovarian Cancer SO325	GSM657627	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.31	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657627/suppl/GSM657627_SO325.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.31	Late-stage high-grade ovarian cancer
GSM657628	Ovarian Cancer SO334	GSM657628	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.35	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657628/suppl/GSM657628_SO334.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.35	Late-stage high-grade ovarian cancer
GSM657629	Ovarian Cancer SO342	GSM657629	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 2.89	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657629/suppl/GSM657629_SO342.CEL.gz	22283	DOD (dead of disease)	Optimal	2.89	Late-stage high-grade ovarian cancer
GSM657630	Ovarian Cancer SO347	GSM657630	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 7.85	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657630/suppl/GSM657630_SO347.CEL.gz	22283	DOD (dead of disease)	Optimal	7.85	Late-stage high-grade ovarian cancer
GSM657631	Ovarian Cancer SO36	GSM657631	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: AWD (alive with disease)	survival years: 4.39	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657631/suppl/GSM657631_SO36RE.CEL.gz	22283	AWD (alive with disease)	Suboptimal	4.39	Late-stage high-grade ovarian cancer
GSM657632	Ovarian Cancer SO362	GSM657632	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 3.55	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657632/suppl/GSM657632_SO362.CEL.gz	22283	DOD (dead of disease)	Optimal	3.55	Late-stage high-grade ovarian cancer
GSM657633	Ovarian Cancer SO367	GSM657633	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 6.51	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657633/suppl/GSM657633_SO367.CEL.gz	22283	DOD (dead of disease)	Optimal	6.51	Late-stage high-grade ovarian cancer
GSM657634	Ovarian Cancer SO375	GSM657634	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 8.12	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657634/suppl/GSM657634_SO375.CEL.gz	22283	NED (no evidence of disease)	Optimal	8.12	Late-stage high-grade ovarian cancer
GSM657635	Ovarian Cancer SO38	GSM657635	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 2.74	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657635/suppl/GSM657635_SO38.CEL.gz	22283	DOD (dead of disease)	Optimal	2.74	Late-stage high-grade ovarian cancer
GSM657636	Ovarian Cancer SO387	GSM657636	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 1.47	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657636/suppl/GSM657636_SO387.CEL.gz	22283	DOD (dead of disease)	Optimal	1.47	Late-stage high-grade ovarian cancer
GSM657637	Ovarian Cancer SO388	GSM657637	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.97	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657637/suppl/GSM657637_SO388.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.97	Late-stage high-grade ovarian cancer
GSM657638	Ovarian Cancer SO393	GSM657638	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 3.95	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657638/suppl/GSM657638_SO393.CEL.gz	22283	DOD (dead of disease)	Suboptimal	3.95	Late-stage high-grade ovarian cancer
GSM657639	Ovarian Cancer SO395	GSM657639	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 3.97	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657639/suppl/GSM657639_SO395.CEL.gz	22283	DOD (dead of disease)	Optimal	3.97	Late-stage high-grade ovarian cancer
GSM657640	Ovarian Cancer SO396	GSM657640	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.69	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657640/suppl/GSM657640_SO396.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.69	Late-stage high-grade ovarian cancer
GSM657641	Ovarian Cancer SO4	GSM657641	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 0.82	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657641/suppl/GSM657641_SO4.CEL.gz	22283	DOD (dead of disease)	Optimal	0.82	Late-stage high-grade ovarian cancer
GSM657642	Ovarian Cancer SO400	GSM657642	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: NED (no evidence of disease)	survival years: 10.09	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657642/suppl/GSM657642_SO400.CEL.gz	22283	NED (no evidence of disease)	Suboptimal	10.09	Late-stage high-grade ovarian cancer
GSM657643	Ovarian Cancer SO401	GSM657643	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 1.48	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657643/suppl/GSM657643_SO401.CEL.gz	22283	DOD (dead of disease)	Optimal	1.48	Late-stage high-grade ovarian cancer
GSM657644	Ovarian Cancer SO402	GSM657644	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: AWD (alive with disease)	survival years: 10.04	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657644/suppl/GSM657644_SO402.CEL.gz	22283	AWD (alive with disease)	Suboptimal	10.04	Late-stage high-grade ovarian cancer
GSM657645	Ovarian Cancer SO404	GSM657645	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.59	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657645/suppl/GSM657645_SO404.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.59	Late-stage high-grade ovarian cancer
GSM657646	Ovarian Cancer SO409	GSM657646	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 3.68	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657646/suppl/GSM657646_SO409.CEL.gz	22283	DOD (dead of disease)	Optimal	3.68	Late-stage high-grade ovarian cancer
GSM657647	Ovarian Cancer SO418	GSM657647	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 1.34	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657647/suppl/GSM657647_SO418.CEL.gz	22283	DOD (dead of disease)	Optimal	1.34	Late-stage high-grade ovarian cancer
GSM657648	Ovarian Cancer SO420	GSM657648	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 9.02	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657648/suppl/GSM657648_SO420.CEL.gz	22283	DOD (dead of disease)	Suboptimal	9.02	Late-stage high-grade ovarian cancer
GSM657649	Ovarian Cancer SO420b	GSM657649	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.1	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657649/suppl/GSM657649_SO420b.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.1	Late-stage high-grade ovarian cancer
GSM657650	Ovarian Cancer SO421	GSM657650	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 2.57	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657650/suppl/GSM657650_SO421.CEL.gz	22283	DOD (dead of disease)	Suboptimal	2.57	Late-stage high-grade ovarian cancer
GSM657651	Ovarian Cancer SO422	GSM657651	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.97	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657651/suppl/GSM657651_SO422.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.97	Late-stage high-grade ovarian cancer
GSM657652	Ovarian Cancer SO422b	GSM657652	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: NED (no evidence of disease)	survival years: 13.65	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657652/suppl/GSM657652_SO422b.CEL.gz	22283	NED (no evidence of disease)	Suboptimal	13.65	Late-stage high-grade ovarian cancer
GSM657653	Ovarian Cancer SO423	GSM657653	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: AWD (alive with disease)	survival years: 13.46	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657653/suppl/GSM657653_SO423.CEL.gz	22283	AWD (alive with disease)	Suboptimal	13.46	Late-stage high-grade ovarian cancer
GSM657654	Ovarian Cancer SO426	GSM657654	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 13.5	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657654/suppl/GSM657654_SO426.CEL.gz	22283	AWD (alive with disease)	Optimal	13.5	Late-stage high-grade ovarian cancer
GSM657655	Ovarian Cancer SO428	GSM657655	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 2.62	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657655/suppl/GSM657655_SO428.CEL.gz	22283	DOD (dead of disease)	Optimal	2.62	Late-stage high-grade ovarian cancer
GSM657656	Ovarian Cancer SO428b	GSM657656	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 3.74	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657656/suppl/GSM657656_SO428b.CEL.gz	22283	DOD (dead of disease)	Optimal	3.74	Late-stage high-grade ovarian cancer
GSM657657	Ovarian Cancer SO429	GSM657657	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 2.53	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657657/suppl/GSM657657_SO429.CEL.gz	22283	DOD (dead of disease)	Optimal	2.53	Late-stage high-grade ovarian cancer
GSM657658	Ovarian Cancer SO434	GSM657658	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 1.98	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657658/suppl/GSM657658_SO434.CEL.gz	22283	DOD (dead of disease)	Optimal	1.98	Late-stage high-grade ovarian cancer
GSM657659	Ovarian Cancer SO44	GSM657659	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: NED (no evidence of disease)	survival years: 6.32	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657659/suppl/GSM657659_SO44.CEL.gz	22283	NED (no evidence of disease)	Suboptimal	6.32	Late-stage high-grade ovarian cancer
GSM657660	Ovarian Cancer SO46	GSM657660	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.82	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657660/suppl/GSM657660_SO46.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.82	Late-stage high-grade ovarian cancer
GSM657661	Ovarian Cancer SO475	GSM657661	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 3.19	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657661/suppl/GSM657661_SO475.CEL.gz	22283	DOD (dead of disease)	Optimal	3.19	Late-stage high-grade ovarian cancer
GSM657662	Ovarian Cancer SO479	GSM657662	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 5.9	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657662/suppl/GSM657662_SO479.CEL.gz	22283	DOD (dead of disease)	Suboptimal	5.9	Late-stage high-grade ovarian cancer
GSM657663	Ovarian Cancer SO481	GSM657663	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 4.88	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657663/suppl/GSM657663_SO481.CEL.gz	22283	DOD (dead of disease)	Suboptimal	4.88	Late-stage high-grade ovarian cancer
GSM657664	Ovarian Cancer SO483	GSM657664	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.4	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657664/suppl/GSM657664_SO483.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.4	Late-stage high-grade ovarian cancer
GSM657665	Ovarian Cancer SO487	GSM657665	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 7.22	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657665/suppl/GSM657665_SO487.CEL.gz	22283	DOD (dead of disease)	Optimal	7.22	Late-stage high-grade ovarian cancer
GSM657666	Ovarian Cancer SO489	GSM657666	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 5.41	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657666/suppl/GSM657666_SO489.CEL.gz	22283	DOD (dead of disease)	Suboptimal	5.41	Late-stage high-grade ovarian cancer
GSM657667	Ovarian Cancer SO490	GSM657667	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 10.73	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657667/suppl/GSM657667_SO490.CEL.gz	22283	AWD (alive with disease)	Optimal	10.73	Late-stage high-grade ovarian cancer
GSM657668	Ovarian Cancer SO5	GSM657668	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 7.43	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657668/suppl/GSM657668_SO5.CEL.gz	22283	DOD (dead of disease)	Suboptimal	7.43	Late-stage high-grade ovarian cancer
GSM657669	Ovarian Cancer SO500	GSM657669	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 2.33	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657669/suppl/GSM657669_SO500.CEL.gz	22283	DOD (dead of disease)	Optimal	2.33	Late-stage high-grade ovarian cancer
GSM657670	Ovarian Cancer SO501	GSM657670	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 10.87	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657670/suppl/GSM657670_SO501.CEL.gz	22283	DOD (dead of disease)	Optimal	10.87	Late-stage high-grade ovarian cancer
GSM657671	Ovarian Cancer SO502	GSM657671	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 8.46	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657671/suppl/GSM657671_SO502.CEL.gz	22283	DOD (dead of disease)	Suboptimal	8.46	Late-stage high-grade ovarian cancer
GSM657672	Ovarian Cancer SO504	GSM657672	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: NED (no evidence of disease)	survival years: 11.78	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657672/suppl/GSM657672_SO504.CEL.gz	22283	NED (no evidence of disease)	Suboptimal	11.78	Late-stage high-grade ovarian cancer
GSM657673	Ovarian Cancer SO505	GSM657673	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 11.59	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657673/suppl/GSM657673_SO505.CEL.gz	22283	NED (no evidence of disease)	Optimal	11.59	Late-stage high-grade ovarian cancer
GSM657674	Ovarian Cancer SO506	GSM657674	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.37	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657674/suppl/GSM657674_SO506.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.37	Late-stage high-grade ovarian cancer
GSM657675	Ovarian Cancer SO507	GSM657675	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 6.81	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657675/suppl/GSM657675_SO507.CEL.gz	22283	DOD (dead of disease)	Optimal	6.81	Late-stage high-grade ovarian cancer
GSM657676	Ovarian Cancer SO509	GSM657676	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.84	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657676/suppl/GSM657676_SO509.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.84	Late-stage high-grade ovarian cancer
GSM657677	Ovarian Cancer SO511	GSM657677	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.66	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657677/suppl/GSM657677_SO511.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.66	Late-stage high-grade ovarian cancer
GSM657678	Ovarian Cancer SO57	GSM657678	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.88	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657678/suppl/GSM657678_SO57.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.88	Late-stage high-grade ovarian cancer
GSM657679	Ovarian Cancer SO58	GSM657679	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.8	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657679/suppl/GSM657679_SO58.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.8	Late-stage high-grade ovarian cancer
GSM657680	Ovarian Cancer SO59	GSM657680	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 2.03	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657680/suppl/GSM657680_SO59.CEL.gz	22283	DOD (dead of disease)	Optimal	2.03	Late-stage high-grade ovarian cancer
GSM657681	Ovarian Cancer SO60	GSM657681	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 2.18	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657681/suppl/GSM657681_SO60.CEL.gz	22283	DOD (dead of disease)	Suboptimal	2.18	Late-stage high-grade ovarian cancer
GSM657682	Ovarian Cancer SO600	GSM657682	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 8.82	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657682/suppl/GSM657682_SO600.CEL.gz	22283	DOD (dead of disease)	Suboptimal	8.82	Late-stage high-grade ovarian cancer
GSM657683	Ovarian Cancer SO603	GSM657683	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 2.25	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657683/suppl/GSM657683_SO603.CEL.gz	22283	DOD (dead of disease)	Suboptimal	2.25	Late-stage high-grade ovarian cancer
GSM657684	Ovarian Cancer SO604	GSM657684	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.56	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657684/suppl/GSM657684_SO604.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.56	Late-stage high-grade ovarian cancer
GSM657685	Ovarian Cancer SO607	GSM657685	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 6.88	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657685/suppl/GSM657685_SO607.CEL.gz	22283	DOD (dead of disease)	Suboptimal	6.88	Late-stage high-grade ovarian cancer
GSM657686	Ovarian Cancer SO609	GSM657686	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 5.63	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657686/suppl/GSM657686_SO609.CEL.gz	22283	DOD (dead of disease)	Suboptimal	5.63	Late-stage high-grade ovarian cancer
GSM657687	Ovarian Cancer SO61	GSM657687	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 5.8	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657687/suppl/GSM657687_SO61.CEL.gz	22283	NED (no evidence of disease)	Optimal	5.8	Late-stage high-grade ovarian cancer
GSM657688	Ovarian Cancer SO610	GSM657688	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 6.49	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657688/suppl/GSM657688_SO610.CEL.gz	22283	DOD (dead of disease)	Suboptimal	6.49	Late-stage high-grade ovarian cancer
GSM657689	Ovarian Cancer SO613	GSM657689	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 6.54	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657689/suppl/GSM657689_SO613.CEL.gz	22283	DOD (dead of disease)	Optimal	6.54	Late-stage high-grade ovarian cancer
GSM657690	Ovarian Cancer SO67	GSM657690	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.79	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657690/suppl/GSM657690_SO67.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.79	Late-stage high-grade ovarian cancer
GSM657691	Ovarian Cancer SO68	GSM657691	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 5.43	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657691/suppl/GSM657691_SO68.CEL.gz	22283	NED (no evidence of disease)	Optimal	5.43	Late-stage high-grade ovarian cancer
GSM657692	Ovarian Cancer SO69	GSM657692	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 4.55	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657692/suppl/GSM657692_SO69.CEL.gz	22283	DOD (dead of disease)	Suboptimal	4.55	Late-stage high-grade ovarian cancer
GSM657693	Ovarian Cancer SO7	GSM657693	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 5.4	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657693/suppl/GSM657693_SO7.CEL.gz	22283	DOD (dead of disease)	Optimal	5.4	Late-stage high-grade ovarian cancer
GSM657694	Ovarian Cancer SO70	GSM657694	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 2.54	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657694/suppl/GSM657694_SO70.CEL.gz	22283	DOD (dead of disease)	Suboptimal	2.54	Late-stage high-grade ovarian cancer
GSM657695	Ovarian Cancer SO71	GSM657695	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 4.67	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657695/suppl/GSM657695_SO71.CEL.gz	22283	DOD (dead of disease)	Suboptimal	4.67	Late-stage high-grade ovarian cancer
GSM657696	Ovarian Cancer SO73	GSM657696	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: AWD (alive with disease)	survival years: 5.27	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657696/suppl/GSM657696_SO73.CEL.gz	22283	AWD (alive with disease)	Suboptimal	5.27	Late-stage high-grade ovarian cancer
GSM657697	Ovarian Cancer SO74	GSM657697	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 0.52	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657697/suppl/GSM657697_SO74.CEL.gz	22283	DOD (dead of disease)	Optimal	0.52	Late-stage high-grade ovarian cancer
GSM657698	Ovarian Cancer SO76	GSM657698	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: NED (no evidence of disease)	survival years: 4.88	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657698/suppl/GSM657698_SO76RE.CEL.gz	22283	NED (no evidence of disease)	Suboptimal	4.88	Late-stage high-grade ovarian cancer
GSM657699	Ovarian Cancer SO77	GSM657699	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.71	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657699/suppl/GSM657699_SO77.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.71	Late-stage high-grade ovarian cancer
GSM657700	Ovarian Cancer SO78	GSM657700	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: DOD (dead of disease)	survival years: 3.94	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657700/suppl/GSM657700_SO78.CEL.gz	22283	DOD (dead of disease)	Optimal	3.94	Late-stage high-grade ovarian cancer
GSM657701	Ovarian Cancer SO79	GSM657701	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: NED (no evidence of disease)	survival years: 4.89	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657701/suppl/GSM657701_SO79.CEL.gz	22283	NED (no evidence of disease)	Suboptimal	4.89	Late-stage high-grade ovarian cancer
GSM657702	Ovarian Cancer SO8	GSM657702	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 7.97	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657702/suppl/GSM657702_SO8.CEL.gz	22283	AWD (alive with disease)	Optimal	7.97	Late-stage high-grade ovarian cancer
GSM657703	Ovarian Cancer SO80	GSM657703	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: AWD (alive with disease)	survival years: 4.46	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657703/suppl/GSM657703_SO80.CEL.gz	22283	AWD (alive with disease)	Optimal	4.46	Late-stage high-grade ovarian cancer
GSM657704	Ovarian Cancer SO82	GSM657704	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.81	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657704/suppl/GSM657704_SO82.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.81	Late-stage high-grade ovarian cancer
GSM657705	Ovarian Cancer SO83	GSM657705	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: NED (no evidence of disease)	survival years: 4.9	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657705/suppl/GSM657705_SO83.CEL.gz	22283	NED (no evidence of disease)	Suboptimal	4.9	Late-stage high-grade ovarian cancer
GSM657706	Ovarian Cancer SO84	GSM657706	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 1.12	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657706/suppl/GSM657706_SO84.CEL.gz	22283	DOD (dead of disease)	Suboptimal	1.12	Late-stage high-grade ovarian cancer
GSM657707	Ovarian Cancer SO85	GSM657707	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 0.74	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657707/suppl/GSM657707_SO85.CEL.gz	22283	DOD (dead of disease)	Suboptimal	0.74	Late-stage high-grade ovarian cancer
GSM657708	Ovarian Cancer SO86	GSM657708	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: AWD (alive with disease)	survival years: 4.96	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657708/suppl/GSM657708_SO86RE.CEL.gz	22283	AWD (alive with disease)	Suboptimal	4.96	Late-stage high-grade ovarian cancer
GSM657709	Ovarian Cancer SO87	GSM657709	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 4.74	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657709/suppl/GSM657709_SO87.CEL.gz	22283	NED (no evidence of disease)	Optimal	4.74	Late-stage high-grade ovarian cancer
GSM657710	Ovarian Cancer SO88	GSM657710	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: NED (no evidence of disease)	survival years: 4.76	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657710/suppl/GSM657710_SO88.CEL.gz	22283	NED (no evidence of disease)	Suboptimal	4.76	Late-stage high-grade ovarian cancer
GSM657711	Ovarian Cancer SO89	GSM657711	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: AWD (alive with disease)	survival years: 4.66	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657711/suppl/GSM657711_SO89.CEL.gz	22283	AWD (alive with disease)	Suboptimal	4.66	Late-stage high-grade ovarian cancer
GSM657712	Ovarian Cancer SO91	GSM657712	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Optimal	status: NED (no evidence of disease)	survival years: 4.63	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657712/suppl/GSM657712_SO91.CEL.gz	22283	NED (no evidence of disease)	Optimal	4.63	Late-stage high-grade ovarian cancer
GSM657713	Ovarian Cancer SO94	GSM657713	Public on Jan 20 2011	Jan 19 2011	Jan 20 2011	RNA	1	Ovarian tumor	Homo sapiens	tissue: Late-stage high-grade ovarian cancer	surgery outcome: Suboptimal	status: DOD (dead of disease)	survival years: 3.73	Tumor specimens were obtained from 185 previously untreated late-stage (III–IV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control	total RNA	Total RNA was isolated using the RNeasy Micro kit (Qiagen)	Biotin	Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification	9606	A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).	Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)	Gene expression data from late-stage high-grade ovarian cancer	Robust Multi-Array Analysis was performed	GPL96	Michael,,Birrer	mbirrer@partners.org	6177244800	Surgical Oncology Research Labs	Medicine	MGH	70 Blossom Street	Boston	MA	02114	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM657nnn/GSM657713/suppl/GSM657713_SO94.CEL.gz	22283	DOD (dead of disease)	Suboptimal	3.73	Late-stage high-grade ovarian cancer
